The development of activating and inhibiting camelid VHH domains against human orotein kinase C eosilon
Gespeichert in:
| Veröffentlicht in: | European journal of pharmaceutical sciences 2011, Vol.42 (4), p.332-339 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 339 |
|---|---|
| container_issue | 4 |
| container_start_page | 332 |
| container_title | European journal of pharmaceutical sciences |
| container_volume | 42 |
| creator | PAALANEN, Milla M. I EKOKOSKI, Elina EL KHATTABI, Mohamed TUOMINEN, Raimo K THEO VERRIPS, C BOONSTRA, Johannes BLANCHETOT, Christophe |
| description | |
| format | Article |
| fullrecord | <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_23953244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23953244</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_239532443</originalsourceid><addsrcrecordid>eNqNyk0KwjAQQOEgCtafO8zGZSG2atu1KD2AuJWxnbajyaQ0UfD2ongAVx8P3khF6zwrYp0leqwiXSR5rIs8m6qZ9zet9S7PdKTaU0dQ05OM6y1JANcAVoGfGFhaQKmBpeMrf7NCS4ZrOJcl1M4iiwdsPwToHhYF3OACscCdBT3BHsh5Nk4WatKg8bT8OVer4-G0L-MefYWmGVAq9pd-YIvD65KkxTZNNpv03-8NdIBKzg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The development of activating and inhibiting camelid VHH domains against human orotein kinase C eosilon</title><source>Elsevier ScienceDirect Journals Complete</source><creator>PAALANEN, Milla M. I ; EKOKOSKI, Elina ; EL KHATTABI, Mohamed ; TUOMINEN, Raimo K ; THEO VERRIPS, C ; BOONSTRA, Johannes ; BLANCHETOT, Christophe</creator><creatorcontrib>PAALANEN, Milla M. I ; EKOKOSKI, Elina ; EL KHATTABI, Mohamed ; TUOMINEN, Raimo K ; THEO VERRIPS, C ; BOONSTRA, Johannes ; BLANCHETOT, Christophe</creatorcontrib><identifier>ISSN: 0928-0987</identifier><identifier>EISSN: 1879-0720</identifier><language>eng</language><publisher>Kindlington: Elsevier</publisher><subject>Biological and medical sciences ; General pharmacology ; Medical sciences ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments</subject><ispartof>European journal of pharmaceutical sciences, 2011, Vol.42 (4), p.332-339</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23953244$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>PAALANEN, Milla M. I</creatorcontrib><creatorcontrib>EKOKOSKI, Elina</creatorcontrib><creatorcontrib>EL KHATTABI, Mohamed</creatorcontrib><creatorcontrib>TUOMINEN, Raimo K</creatorcontrib><creatorcontrib>THEO VERRIPS, C</creatorcontrib><creatorcontrib>BOONSTRA, Johannes</creatorcontrib><creatorcontrib>BLANCHETOT, Christophe</creatorcontrib><title>The development of activating and inhibiting camelid VHH domains against human orotein kinase C eosilon</title><title>European journal of pharmaceutical sciences</title><subject>Biological and medical sciences</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><issn>0928-0987</issn><issn>1879-0720</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNyk0KwjAQQOEgCtafO8zGZSG2atu1KD2AuJWxnbajyaQ0UfD2ongAVx8P3khF6zwrYp0leqwiXSR5rIs8m6qZ9zet9S7PdKTaU0dQ05OM6y1JANcAVoGfGFhaQKmBpeMrf7NCS4ZrOJcl1M4iiwdsPwToHhYF3OACscCdBT3BHsh5Nk4WatKg8bT8OVer4-G0L-MefYWmGVAq9pd-YIvD65KkxTZNNpv03-8NdIBKzg</recordid><startdate>2011</startdate><enddate>2011</enddate><creator>PAALANEN, Milla M. I</creator><creator>EKOKOSKI, Elina</creator><creator>EL KHATTABI, Mohamed</creator><creator>TUOMINEN, Raimo K</creator><creator>THEO VERRIPS, C</creator><creator>BOONSTRA, Johannes</creator><creator>BLANCHETOT, Christophe</creator><general>Elsevier</general><scope>IQODW</scope></search><sort><creationdate>2011</creationdate><title>The development of activating and inhibiting camelid VHH domains against human orotein kinase C eosilon</title><author>PAALANEN, Milla M. I ; EKOKOSKI, Elina ; EL KHATTABI, Mohamed ; TUOMINEN, Raimo K ; THEO VERRIPS, C ; BOONSTRA, Johannes ; BLANCHETOT, Christophe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_239532443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Biological and medical sciences</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PAALANEN, Milla M. I</creatorcontrib><creatorcontrib>EKOKOSKI, Elina</creatorcontrib><creatorcontrib>EL KHATTABI, Mohamed</creatorcontrib><creatorcontrib>TUOMINEN, Raimo K</creatorcontrib><creatorcontrib>THEO VERRIPS, C</creatorcontrib><creatorcontrib>BOONSTRA, Johannes</creatorcontrib><creatorcontrib>BLANCHETOT, Christophe</creatorcontrib><collection>Pascal-Francis</collection><jtitle>European journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PAALANEN, Milla M. I</au><au>EKOKOSKI, Elina</au><au>EL KHATTABI, Mohamed</au><au>TUOMINEN, Raimo K</au><au>THEO VERRIPS, C</au><au>BOONSTRA, Johannes</au><au>BLANCHETOT, Christophe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The development of activating and inhibiting camelid VHH domains against human orotein kinase C eosilon</atitle><jtitle>European journal of pharmaceutical sciences</jtitle><date>2011</date><risdate>2011</risdate><volume>42</volume><issue>4</issue><spage>332</spage><epage>339</epage><pages>332-339</pages><issn>0928-0987</issn><eissn>1879-0720</eissn><cop>Kindlington</cop><pub>Elsevier</pub></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0928-0987 |
| ispartof | European journal of pharmaceutical sciences, 2011, Vol.42 (4), p.332-339 |
| issn | 0928-0987 1879-0720 |
| language | eng |
| recordid | cdi_pascalfrancis_primary_23953244 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Biological and medical sciences General pharmacology Medical sciences Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments |
| title | The development of activating and inhibiting camelid VHH domains against human orotein kinase C eosilon |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A01%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20development%20of%20activating%20and%20inhibiting%20camelid%20VHH%20domains%20against%20human%20orotein%20kinase%20C%20eosilon&rft.jtitle=European%20journal%20of%20pharmaceutical%20sciences&rft.au=PAALANEN,%20Milla%20M.%20I&rft.date=2011&rft.volume=42&rft.issue=4&rft.spage=332&rft.epage=339&rft.pages=332-339&rft.issn=0928-0987&rft.eissn=1879-0720&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E23953244%3C/pascalfrancis%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |